HTG Molecular Diagnostics Inc (NASDAQ:HTGM) is scheduled to be announcing its earnings results after the market closes on Wednesday, March 22nd. Analysts expect the company to announce earnings of ($0.76) per share for the quarter.

Earnings History for HTG Molecular Diagnostics (NASDAQ:HTGM)

HTG Molecular Diagnostics Inc (NASDAQ:HTGM) opened at 2.14 on Tuesday. The company has a 50 day moving average of $2.11 and a 200-day moving average of $2.21. The stock’s market capitalization is $15.12 million. HTG Molecular Diagnostics Inc has a 12-month low of $1.20 and a 12-month high of $4.45.

Separately, Zacks Investment Research downgraded HTG Molecular Diagnostics from a “buy” rating to a “hold” rating in a report on Tuesday, January 17th. One investment analyst has rated the stock with a hold rating and four have issued a buy rating to the company. The stock has a consensus rating of “Buy” and an average price target of $5.25.

This article was originally published by and is the sole property of American Banking News. If you happen to be reading this article on another website, it was stolen and illegally republished in violation of U.S. and International copyright law. The original version of this story can be read at

Your IP Address:

HTG Molecular Diagnostics Company Profile

HTG Molecular Diagnostics, Inc is a commercial-stage company that develops and markets a technology platform to facilitate the routine use of complex molecular profiling. The Company’s HTG Edge and HTG EdgeSeq platforms, consisting of instrumentation, consumables and software analytics, are used in sample profiling applications, including tumor profiling, molecular diagnostic testing and biomarker development.

5 Day Chart for NASDAQ:HTGM

Receive News & Ratings for HTG Molecular Diagnostics Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HTG Molecular Diagnostics Inc and related companies with's FREE daily email newsletter.